Interaction between celecoxib and docetaxel or cisplatin in human cell lines of ovarian cancer and colon cancer is independent of COX-2 expression levels
MNA Bijman, CA Hermelink, MPA van Berkel… - Biochemical …, 2008 - Elsevier
Celecoxib, an inhibitor of cyclooxygenase-2 (COX-2), is being investigated for enhancement
of chemotherapy efficacy in cancer clinical trials. We determined whether continuous …
of chemotherapy efficacy in cancer clinical trials. We determined whether continuous …
[PDF][PDF] Interaction between celecoxib and docetaxel or cisplatin in human cell lines of ovarian cancer and colon cancer is independent of COX-2 expression levels
MNA Bijman, CA Hermelink… - … : A study on its role as …, 2009 - research.vumc.nl
Celecoxib, an inhibitor of cyclooxygenase-2 (COX-2), is being investigated for enhancement
of chemotherapy efficacy in cancer clinical trials. We determined whether continuous …
of chemotherapy efficacy in cancer clinical trials. We determined whether continuous …
[引用][C] Interaction between celecoxib and docetaxel or cisplatin in human cell lines of ovarian cancer and colon cancer is independent of COX-2 expression levels
MNA BIJMAN, CA HERMELINK… - Biochemical …, 2008 - pascal-francis.inist.fr
Interaction between celecoxib and docetaxel or cisplatin in human cell lines of ovarian cancer
and colon cancer is independent of COX-2 expression levels CNRS Inist Pascal-Francis CNRS …
and colon cancer is independent of COX-2 expression levels CNRS Inist Pascal-Francis CNRS …
[引用][C] Interaction between celecoxib and docetaxel or cisplatin in human cell lines of ovarian cancer and colon cancer is independent of COX-2 expression levels
MN Bijman, CA Hermelink… - Biochemical …, 2008 - researchinformation.amsterdamumc …
Interaction between celecoxib and docetaxel or cisplatin in human cell lines of ovarian cancer
and colon cancer is independent of COX-2 expression levels — Amsterdam UMC research …
and colon cancer is independent of COX-2 expression levels — Amsterdam UMC research …
Interaction between celecoxib and docetaxel or cisplatin in human cell lines of ovarian cancer and colon cancer is independent of COX-2 expression levels.
MN Bijman, CA Hermelink, MP van Berkel… - Biochemical …, 2007 - europepmc.org
Celecoxib, an inhibitor of cyclooxygenase-2 (COX-2), is being investigated for enhancement
of chemotherapy efficacy in cancer clinical trials. We determined whether continuous …
of chemotherapy efficacy in cancer clinical trials. We determined whether continuous …
[PDF][PDF] Interaction between celecoxib and docetaxel or cisplatin in human cell lines of ovarian cancer and colon cancer is independent of COX-2 expression levels
MNA Bijman, CA Hermelink, MPA van Berkel… - VU Research …, 2009 - research.vu.nl
Celecoxib, an inhibitor of cyclooxygenase-2 (COX-2), is being investigated for enhancement
of chemotherapy efficacy in cancer clinical trials. We determined whether continuous …
of chemotherapy efficacy in cancer clinical trials. We determined whether continuous …
Interaction between celecoxib and docetaxel or cisplatin in human cell lines of ovarian cancer and colon cancer is independent of COX-2 expression levels
MNA Bijman, CA Hermelink, MPA van Berkel… - Biochemical …, 2008 - infona.pl
Celecoxib, an inhibitor of cyclooxygenase-2 (COX-2), is being investigated for enhancement
of chemotherapy efficacy in cancer clinical trials. We determined whether continuous …
of chemotherapy efficacy in cancer clinical trials. We determined whether continuous …
Interaction between celecoxib and docetaxel or cisplatin in human cell lines of ovarian cancer and colon cancer is independent of COX-2 expression levels
MNA Bijman, CA Hermelink… - Biochemical …, 2008 - pubmed.ncbi.nlm.nih.gov
Celecoxib, an inhibitor of cyclooxygenase-2 (COX-2), is being investigated for enhancement
of chemotherapy efficacy in cancer clinical trials. We determined whether continuous …
of chemotherapy efficacy in cancer clinical trials. We determined whether continuous …
[PDF][PDF] Interaction between celecoxib and docetaxel or cisplatin in human cell lines of ovarian cancer and colon cancer is independent of COX-2 expression levels
MNA Bijman, CA Hermelink, MPA van Berkel… - VU Research …, 2009 - research.vu.nl
Celecoxib, an inhibitor of cyclooxygenase-2 (COX-2), is being investigated for enhancement
of chemotherapy efficacy in cancer clinical trials. We determined whether continuous …
of chemotherapy efficacy in cancer clinical trials. We determined whether continuous …